Visual Performance With Spatial Light Modulator
Visual Performance After Optically Correcting the Eye's Aberration With a Spatial Light Modulator
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
Eye's aberrations have been known to degrade human visual performance and the visual performance is significantly improved when correcting the aberrations in the central visual field. However, how the aberration correction affects the peripheral visual performance is not well understood. Moreover, how central and peripheral vision interacts remains unclear. To conduct the study, we will use an adaptive optics vision simulator equipped with a Shack-Hartmann wavefront sensor and a spatial light modulator (see details in procedures section of the protocol). This system is capable of noninvasively controlling the eye's optical quality and evaluating visual performance simultaneously over a wide area of visual space. This study provides insights into the visual performance in the periphery visual field, and interaction between central and peripheral visual fields. The goal of this study is to evaluate the visual performance at central and peripheral visual fields after correcting the ocular aberrations. An optical system equipped with a liquid crystal spatial light modulator will be used to achieve this goal non-invasively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2021
CompletedFirst Submitted
Initial submission to the registry
November 11, 2021
CompletedFirst Posted
Study publicly available on registry
November 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedNovember 26, 2021
November 1, 2021
1 year
November 11, 2021
November 23, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
Visual acuity
Snellen "Tumbling E" method will be used to determine the smallest letter that a subject can see.
up to 6 separate sessions (each session taking up to 2 hours)
Contrast sensitivity
Light and dark sinusoidal stripes (Gabor gratings) will used to determine the smallest contrast that a subject can see
up to 6 separate sessions (each session taking up to 2 hours)
Contrast perception
Light and dark sinusoidal stripes (Gabor gratings) will used to determine differences in contrast perceived by the central and peripheral visual system
up to 6 separate sessions (each session taking up to 2 hours)
Study Arms (1)
normal healthy group
EXPERIMENTALSpatial light modulator
Interventions
This device compensates for the eye's optical imperfections (aberrations) at the foveal and peripheral retina.
Eligibility Criteria
You may qualify if:
- Is between the ages of 18 and 60.
- Has normal corneas i.e. no corneal infections, no systemic pink eye, no clinically significant dry eye, and no corneal dystrophies.
- Has refractive errors less than +/- 10.0 Diopters in both eyes.
You may not qualify if:
- A person will be excluded from the study if he/she:
- Adults between the ages of 18-60 who are unable to give informed consent
- Individuals below 18 years old
- Individuals above the age of 60
- Pregnant women (self-reporting, hormonal changes may alter the refractive status of the eye)
- Prisoners
- Students for whom you have direct access to/influence on grades
- People who do not understand or speak English
- Has clinically significant dry eye.
- Has clinically significant cataract.
- Has spherical refractive error that exceeds the limits outlined above.
- Is unable to hold his or her head steady for the duration of study measurements.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 11, 2021
First Posted
November 26, 2021
Study Start
November 1, 2021
Primary Completion
November 1, 2022
Study Completion
March 1, 2023
Last Updated
November 26, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share